Press Releases

November 4, 2021

Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab in Acute Ischemic Stroke

Navigation
CompanyOur ProductPipelineAbout strokeMedia
Contact Us
ContactFollow us on LinkedInFollow us on Twitter

Acticor Biotech
Wojo Building
82, avenue du Maine
75014 Paris

+33 (0)6 76 23 38 13

© 2021 Acticor Biotech SA
Legal mentionsPrivacy Policy
email:
contact@acticor-biotech.com